Lord, Abbett & Co’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-275,787
| Closed | -$6.53M | – | 613 |
|
|
2022
Q1 | $6.53M | Buy |
275,787
+112,123
| +69% | +$2.66M | 0.02% | 527 |
|
|
2021
Q4 | $5.6M | Buy |
+163,664
| New | +$5.6M | 0.01% | 542 |
|
|
2021
Q3 | – | Sell |
-138,608
| Closed | -$6.22M | – | 680 |
|
|
2021
Q2 | $6.22M | Buy |
+138,608
| New | +$6.22M | 0.02% | 597 |
|